Todos Medical Ltd. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

SIGNIFICANT TRANSACTIONS (Details Narrative)

SIGNIFICANT TRANSACTIONS (Details Narrative)												1 Months Ended		3 Months Ended						9 Months Ended
SIGNIFICANT TRANSACTIONS (Details Narrative)	Sep. 23, 2021 USD ($) $ / shares shares	Jul. 19, 2021 USD ($)	Jul. 07, 2021 USD ($) $ / shares shares	Jul. 02, 2021 Number $ / shares	May 13, 2021 shares	May 01, 2021 USD ($)	Apr. 27, 2021 USD ($) $ / shares shares	Apr. 09, 2021 USD ($) $ / shares shares	Apr. 09, 2021 USD ($) $ / shares shares	Apr. 09, 2021 USD ($) $ / shares shares	Dec. 31, 2020 USD ($)	Sep. 30, 2021 USD ($) $ / shares	Jan. 22, 2021 USD ($) Number $ / shares shares	Sep. 30, 2021 USD ($) $ / shares shares	Jun. 30, 2021 USD ($)	Mar. 31, 2021 USD ($)	Sep. 30, 2020 USD ($)	Jun. 30, 2020 USD ($)	Mar. 31, 2020 USD ($)	Sep. 30, 2021 USD ($) $ / shares shares	Sep. 30, 2020 USD ($)
Debt principle amount		$ 1,666,000
Shares issued on conversion														$ 7,918,000	$ 1,776,000	$ 6,870,000	$ 1,454,000	$ 902,000	$ 1,586,000
Debt Instrument, Convertible, Conversion Price \| $ / shares				$ 0.05
Debt instrument, trading days \| Number				20,000
Fair value of warrants																				$ (299,000)
Amortization of Debt Discount (Premium)																				2,290,000
Proceeds from issuance of note		$ 1,000,000
Conversion feature										$ 3,007,000
Operating Expenses																				(5,681,000)
Lease expenses																				104
Finanace Expenses [Member]
Operating Expenses														538						753
Detachable Warrants [Member]
Detachable warrant							$ 2,922,000
Convertible Bridge Loan [Member].
Remeasurement expense														0						34,000
Finance expense														$ 2,647,000
Amortization of Debt Discount (Premium)																				$ 2,750,000
Aslano Private Limited [Member]
Success fee percentage												8.00%		8.00%						8.00%
Secured Convertible Equipment Loan Agreement [Member]
Proceeds from loans											$ 450,000
Debt instrument original issue discount, rate											40.00%
Original issue discount on loan											$ 300,000
Debt principle amount											750,000
Incurred incremental and direct costs											$ 54,000
Royalty interest rate											12.50%
Amortization of Debt Issuance Costs														$ 2,207,000						$ 2,414,000
Stock Issued During Period, Shares, New Issues \| shares																				20,000,000
Securities Purchase Agreement [Member]
Stock Issued During Period, Shares, Conversion of Convertible Securities \| shares														81,736,111
Shares issued on conversion														$ 750,000
Beneficial conversion feature	$ 3,000		$ 81,000									$ 243,000
Remeasurement expense	45,000		148,000
Investment												$ 1,127,000		1,127,000						$ 1,127,000
Securities Purchase Agreement [Member] \| First and Second Tranches [Member]
Stock Issued During Period, Shares, New Issues \| shares					240,591,462
Securities Purchase Agreement [Member] \| Family Office Investor [Member]
Debt principle amount								$ 4,286,000	$ 4,286,000	$ 4,286,000
Debt instrument, interest rate								4.00%	4.00%	4.00%
Debt Instrument, Convertible, Conversion Price \| $ / shares								$ 0.0599	$ 0.0599	$ 0.0599
Beneficial conversion feature														143,000						2,166,000
Remeasurement expense														49,000						55,000
Proceeds from issuance of note								$ 3,000,000
Cash proceeds from notes receivable										$ 1,000
Securities Purchase Agreement [Member] \| Yozma [Member]
Cash proceeds from notes receivable							378,000
Securities Purchase Agreement [Member] \| Promissoery Convertible Note [Member]
Debt principle amount	$ 2,857,000		$ 1,536,000
Debt instrument, interest rate	4.00%		4.00%
Debt Instrument, Convertible, Conversion Price \| $ / shares	$ 0.0599		$ 0.0599
Warrants to purchase common stock \| shares	11,924,636		3,440,000
Warrants term	5 years		5 years
Exercise price of warrants \| $ / shares	$ 0.107415		$ 0.107415
Proceeds from issuance of note	$ 2,000,000		$ 1,075,000
Cash proceeds from notes receivable	1,290,000		697,000
Proceeds from Warrant	558,000		121,000
Conversion feature	$ 152,000		$ 257,000
Sales price \| $ / shares			$ 0.10
Securities Purchase Agreement [Member] \| Warrant [Member] \| Family Office Investor [Member]
Warrants term								5 years	5 years	5 years
Exercise price of warrants \| $ / shares								$ 0.107415	$ 0.107415	$ 0.107415
Proceeds from Warrant										$ 508,000
Securities Purchase Agreement [Member] \| Warrant [Member] \| Yozma [Member]
Proceeds from Warrant										$ 2,922,000
Securities Purchase Agreement [Member] \| Maximum [Member] \| Warrant [Member] \| Family Office Investor [Member]
Warrants to purchase common stock \| shares								16,000,000	16,000,000	16,000,000
Securities Purchase Agreement [Member] \| Yozma [Member]
Debt instrument original issue discount, rate													30.00%
Original issue discount on loan													$ 1,457,000
Debt principle amount							$ 4,714,000						$ 4,857,000
Debt instrument, interest rate							4.00%						4.00%
Debt instrument maturity date													Jan. 22, 2022
Debt Instrument, Convertible, Conversion Price \| $ / shares							$ 0.0599						$ 0.07161
Debt instrument, trading days \| Number													10
Debt instrument conversion price, rate													0.20
Debt unpaid loan, interest rate													33.00%
Debt instrument repayment rate													115.00%
Liquidation damages, value													$ 250,000
Proceeds from issuance of note							$ 3,300,000
Securities Purchase Agreement [Member] \| Yozma [Member] \| Warrant [Member]
Proceeds from loans																				272,000
Warrants to purchase common stock \| shares													16,956,929
Warrants term							5 years						5 years
Exercise price of warrants \| $ / shares							$ 0.107415						$ 0.107415
Fair value of loans payable													$ 423,000
Fair value of warrants													861,000
Beneficial conversion feature													$ 2,116,000
Securities Purchase Agreement [Member] \| Yozma [Member] \| Warrant [Member] \| Convertible Bridge Loan [Member].
Beneficial conversion feature																				1,666,000
Remaining amount allocated for host loan instrument																				423,000
Remeasurement expense																				742,000
Finance expense														164,000
Finance income														$ 58,000
Securities Purchase Agreement [Member] \| Yozma [Member] \| Maximum [Member]
Debt unpaid loan, interest rate													18.00%
Debt instrument repayment rate													1.00%
Securities Purchase Agreement [Member] \| Yozma [Member] \| Maximum [Member] \| Warrant [Member]
Warrants to purchase common stock \| shares							16,458,196
Securities Purchase Agreement [Member] \| Family Office Investor [Member] \| Purchaser [Member]
Debt principle amount								$ 4,286,000	$ 4,286,000	$ 4,286,000
Proceeds from issuance of note									$ 3,000,000
Securities Purchase Agreement [Member] \| Family Office Investor [Member] \| Warrant [Member] \| Purchaser [Member]
Warrants to purchase common stock \| shares								16,000,000	16,000,000	16,000,000
Exercise price of warrants \| $ / shares								$ 0.107415	$ 0.107415	$ 0.107415
Loan Agreement [Member]
Additional discount of the convertible bridge loans																				34,000
Immediate charge to finance expenses																				169,000
Deduction of additional paid-in capital																				$ 69,000
First Amendment to Secured Convertible Equipment Loan Agreement [Member] \| Lender [Member]
Original issue discount on loan						$ 320,000
Repayments of debt						450,000
Officer compensation						$ 100,000
Stock issued during period shares restricted stock \| shares																				2,000,000
First Amendment to Secured Convertible Equipment Loan Agreement [Member] \| Lender [Member] \| NIS [Member]
Shares issued, price per share \| $ / shares												$ 0.0001		$ 0.0001						$ 0.0001
Closing Agreement [Member] \| Purchaser [Member]
Investment												$ 88,000		$ 88,000						$ 88,000
Investments												$ 884,000		$ 884,000						$ 884,000
Loss Contingency, Damages Sought																				The Company acknowledges that failure to timely comply with the foregoing obligations will subject the Company to substantial liability under the Registration Agreement, including without limitation liquidated damages in the amount of $250, along with an amount of cash accruing each month equal to the value of 1% of the value of the Tranche 2 Securities
Assignment of Receivable Agreements [Member]
Proceeds from receivable																				$ 1,467,000
Repayment for receivable																				1,117,000
Finance expenses with applicable discount interest																				50,000
Repayment for loans																				$ 400,000